|
Volumn , Issue 55, 1996, Pages
|
C-type natriuretic peptide in chronic renal failure and its action in humans
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALDOSTERONE;
ATRIAL NATRIURETIC FACTOR;
ATRIAL NATRIURETIC FACTOR[4-23]DE[18-22];
UNCLASSIFIED DRUG;
BRAIN NATRIURETIC PEPTIDE;
NATRIURETIC PEPTIDE TYPE C;
NERVE PROTEIN;
PROTEIN;
ADULT;
AGED;
CHRONIC KIDNEY FAILURE;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
DIURESIS;
HUMAN;
HUMAN EXPERIMENT;
KALIURESIS;
KIDNEY FUNCTION;
MALE;
NATRIURESIS;
NORMAL HUMAN;
PRIORITY JOURNAL;
ARTICLE;
BLOOD;
BLOOD PRESSURE;
CLINICAL TRIAL;
DRUG EFFECT;
INTRAVENOUS DRUG ADMINISTRATION;
METABOLISM;
MIDDLE AGED;
ADULT;
AGED;
ALDOSTERONE;
ATRIAL NATRIURETIC FACTOR;
BLOOD PRESSURE;
DIURESIS;
HUMANS;
INJECTIONS, INTRAVENOUS;
KIDNEY FAILURE, CHRONIC;
MALE;
MIDDLE AGED;
NATRIURETIC PEPTIDE, BRAIN;
NATRIURETIC PEPTIDE, C-TYPE;
NERVE TISSUE PROTEINS;
PROTEINS;
|
EID: 0001656802
PISSN: 00986577
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (62)
|
References (0)
|